BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10865414)

  • 1. Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis.
    Chuncharunee S; Archararit N; Ungkanont A; Jootar S; Angchaisuksiri P; Bunyaratavej A; Rojanasthein S; Atichartakarn V
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S95-100. PubMed ID: 10865414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
    Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases).
    Randi ML; Stocco F; Rossi C; Tison T; Girolami A
    J Med; 1991; 22(4-5):213-23. PubMed ID: 1787383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytosis in children.
    Chiarello P; Magnolia M; Rubino M; Liguori SA; Miniero R
    Minerva Pediatr; 2011 Dec; 63(6):507-13. PubMed ID: 22075805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
    Murphy S
    Thromb Haemost; 1997 Jul; 78(1):622-6. PubMed ID: 9198227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and etiology of thrombocytosis in an adult Turkish population.
    Aydogan T; Kanbay M; Alici O; Kosar A
    Platelets; 2006 Aug; 17(5):328-31. PubMed ID: 16928605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases.
    Buss DH; Stuart JJ; Lipscomb GE
    Am J Hematol; 1985 Dec; 20(4):365-72. PubMed ID: 3865532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-reactive protein level in postsplenectomized thalassemic patients.
    Archararit N; Chuncharunee S; Pornvoranunt A; Atamasirikul K; Rachakom B; Atichartakarn V
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S63-9. PubMed ID: 10865409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.
    Orlandi E; Castelli G; Brusamolino E; Canevari A; Morra E; Lazzarino M; Bernasconi C
    Haematologica; 1989; 74(1):45-9. PubMed ID: 2498182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
    Walsh PN; Murphy S; Barry WE
    Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases.
    Buss DH; Cashell AW; O'Connor ML; Richards F; Case LD
    Am J Med; 1994 Mar; 96(3):247-53. PubMed ID: 8154513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of specific thrombotic accidents in patients with thrombocytosis.
    Randi ML; Fabris F; Tison T; Barbone E; Rossi C; Girolami A
    Haematologia (Budap); 1993; 25(3):149-52. PubMed ID: 8119627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis in childhood.
    Heng JT; Tan AM
    Singapore Med J; 1998 Nov; 39(11):485-7. PubMed ID: 10067383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating thrombopoietin in clonal versus reactive thrombocytosis.
    Karakuş S; Ozcebe OI; Haznedaroğlu IC; Göker H; Ozatli D; Koşar A; BüyükaşIk Y; Ertuğrul D; SayInalp N; KirazlI S; Dündar SV
    Hematology; 2002 Feb; 7(1):9-12. PubMed ID: 12171772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia.
    Schwarz J; Pytlík R; Doubek M; Brychtová Y; Dulícek P; Campr V; Kren L; Penka M
    Semin Thromb Hemost; 2006 Apr; 32(3):231-45. PubMed ID: 16673277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
    Zucker S; Mielke CH
    J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
    Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
    Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytosis in neonates and young infants: a report of 25 patients with platelet counts of > or = 1000000 microl(-1).
    Wiedmeier SE; Henry E; Burnett J; Anderson T; Christensen RD
    J Perinatol; 2010 Mar; 30(3):222-6. PubMed ID: 19798040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytosis: age dependent aetiology and analysis of platelet indices for differential diagnosis.
    Syed NN; Usman M; Khurshid M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):628-33. PubMed ID: 17883167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.